For Quick Alerts
For Daily Alerts

Sun Pharma Q3 Profit Jumps 286%


Sun Pharmaceutical Industries Limited reported an impressive 286.1 percent jump in net profit to Rs 1,241.1 crore for the third quarter of the financial year 2018-19 as its American generics business improves. In the same period last year, the company had posted a net profit of Rs 321.5 crore.

Sun Pharma Q3 Profit Jumps 286%

IT should also be noted that the number in December 2017 were impacted by Rs 513.02 crore incurred as exceptional taxes on account of re-measurement of the group's deferred tax assets after the Tax Cut and Jobs Act enacted in the US on 22 October 2017.

The revenues from operations of India's largest drugmaker rose 17 percent in the October-December 2018 quarter to Rs 7,933.25 crore in comparison with Rs 6,782.42 crore.

The EBITDA (earnings before interest, tax, depreciation and amortization) for the quarter under review was at Rs 2,151 crore. The EBITDA margin was at 27.8 percent.

Read more about: sun pharma
Story first published: Tuesday, February 12, 2019, 17:20 [IST]
Company Search
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more